RadiologyHumansCarcinomaHepatocellularLiver NeoplasmsMale
Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy.
Lianhua Zhu, Bo Jiang, Xiang Fei, Yinzhe Xu, Zhe Liu, Wenwen Zhang, Bing Liu, Shichun Lu, Yukun Luo
Published: 202510.1148/radiol.251698
Abstract
Background Accurate assessment of residual viable hepatocellular carcinoma (HCC) after downstaging therapy is essential for optimizing clinical decision-making in patients with unresectable HCC. Purpose To evaluate the diagnostic performance of contr…
Preview only. Read the full abstract at the source